Curist Hemorrhoid Fissure Relief Cream
NDC Package 72559-037-08
Package Information
Curist Hemorrhoid Fissure Relief (lidocaine) cream is a medication used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). This formulation utilizes a cream delivery system. Marketed by Little Pharma, Inc, this product is identified by NDC 72559-037 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2642220 - glycerin 14.4 % / lidocaine 5 % / phenylephrine HCl 0.25 % / white petrolatum 15 % Rectal Cream
- RxCUI: 2642220 - glycerin 144 MG/ML / lidocaine 50 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 72559 - Little Pharma, Inc
- 72559-037 - Curist Hemorrhoid Fissure Relief
- 72559-037-08 - 170 g in 1 TUBE
- 72559-037 - Curist Hemorrhoid Fissure Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72559-037-08 identifies a specific commercial package of 170 g in 1 tube of Curist Hemorrhoid Fissure Relief, a human over the counter drug labeled by Little Pharma, Inc. This cream is formulated for topical use and contains glycerin; lidocaine; petrolatum; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Little Pharma, Inc on May 01, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.
How is this Little Pharma, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72559003708. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.